These results reveal that reduction of SON has a significant effect on blocking GBM cell growth and cancer stem cell maintenance and the expression status of hnRNP A2B1 and RBFOX2 are critical factors that would affect the outcome of SON inhibition in GBM cells. This evidence concerns the gene HNRNPA2B1 and glioblastoma.